China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017
HONG KONG, Aug. 26, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that the Company has been informed that Magnum...
China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2016
HONG KONG, Aug. 20, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its preliminary unaudited financial ...
China Cord Blood Corporation to Report First Quarter of Fiscal 2016 Financial Results
HONG KONG, Aug. 13, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the first quarter of fiscal year 2016 onWednesday, August 19, 2015, after market close. The Company will host a conference call at ...
China Cord Blood Corporation Announces Receipt of Non-Binding Acquisition Proposal
HONG KONG, Aug. 6, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors has recei...
China Cord Blood Corporation Files Its Annual Report on Form 20-F
HONG KONG, July 31, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has filed its Annu...
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2015
HONG KONG, June 19, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its preliminary unaudited financial ...
China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2015 Financial Results
HONG KONG, June 9, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the fourth quarter and full year of fiscal year 2015 onThursday, June 18, 2015, after market close in the US. The Company will host a confere...
China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal
HONG KONG, June 2, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC," the "Company," "we," "us" and "our"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that the Special ...
China Cord Blood Corporation Announces Resignation of an Independent Director
HONG KONG, May 14, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that Mr.Julian J. Wolhardt, one of th...
China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 Held by Cordlife and Magnum and its Ordinary Shares Held by Cordlife
HONG KONG, May 8, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that the Company has been informed...
China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR
HONG KONG, May 4, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that the Company has been informed tha...
April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital
NEW YORK, April 30, 2015 /PRNewswire/ -- The following is an open letter sent April 30, 2015 to the Board of Directors of China Cord Blood Corp (NYSE: CO) from Jayhawk Capital. We trust that the special committee of the independent directors of China Cord Blood Corp ("China Cord") will REJECT th...
China Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, April 29, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding...
China Cord Blood Corporation Announces Receipt of "Going Private" Proposal
HONG KONG, April 27, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors has r...
An Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital
NEW YORK, March 20, 2015 /PRNewswire/ -- The following is an open letter sent March 19, 2015 to the Board of Directors of China Cord Blood Corp (NYSE: CO) from Jayhawk Capital. As a substantial and long term shareholder (Jayhawk Capital has been a shareholder in the company since before it was l...
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015
HONG KONG, Feb. 26, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its preliminary unaudited financi...
China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2015 Financial Results
HONG KONG, Feb. 17, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release its unaudited financial results for the third quarter and first nine months of fiscal 2015 onWednesday, February 25, 2015, after market close in the US. The C...
China Cord Blood Corporation and Cord Blood Registry Enter Into Strategic Collaboration
HONG KONG, Jan. 28, 2015 /PRNewswire/ – China Cord Blood Corporation (CCBC, NYSE: CO), China's first and largest umbilical cord blood bank, and Cord Blood Registry® (CBR®), the world's largest newborn stem cell company, today entered into a memorandum of understanding regarding their strategic co...
China Cord Blood Corporation Announces Results of 2014 Annual General Meeting
HONG KONG, Dec. 11, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2014 Annual Gene...
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2015
HONG KONG, Nov. 26, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial...
